BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38721518)

  • 21. Characteristics, evolution, and outcome of patients with non-infectious uveitis referred for rheumatologic assessment and management: an Egyptian multicenter retrospective study.
    Hassan WA; Medhat BM; Youssef MM; Farag Y; Mostafa N; Alnaggar AR; Behiry ME; Abdel Noor RA; Allam RSHM
    Clin Rheumatol; 2021 Apr; 40(4):1599-1610. PubMed ID: 32876781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uveitis and Scleritis as a Risk Factor for Mortality.
    Lim JZ; Samalia PD; Sims JL; Niederer RL
    Ocul Immunol Inflamm; 2024 Jan; ():1-8. PubMed ID: 38833275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence, prevalence, and risk factors of infectious uveitis and scleritis in the United States: A claims-based analysis.
    Zhang Y; Amin S; Lung KI; Seabury S; Rao N; Toy BC
    PLoS One; 2020; 15(8):e0237995. PubMed ID: 32841267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes of small-incision cataract surgery in patients with uveitis.
    Bhargava R; Pandey K; Mehta B
    Indian J Ophthalmol; 2022 Nov; 70(11):3927-3932. PubMed ID: 36308129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab for non-infectious Uveitis and Scleritis.
    Ng CC; Sy A; Cunningham ET
    J Ophthalmic Inflamm Infect; 2021 Aug; 11(1):23. PubMed ID: 34396463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical patterns and characteristics of uveitis in a secondary hospital in southern China.
    Zheng Y; Zhang LX; Meng QL; Zhang M; Cui Y; Liu QY; Luo ZL; Du LP
    Int J Ophthalmol; 2015; 8(2):337-41. PubMed ID: 25938052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermediate uveitis, posterior uveitis, and panuveitis in the Mid-Atlantic USA.
    Engelhard SB; Patel V; Reddy AK
    Clin Ophthalmol; 2015; 9():1549-55. PubMed ID: 26345421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Etiology of Pediatric Uveitis in a Tertiary Pediatric Eye Hospital in Egypt.
    Abd El Latif E; Mousa R; Tawfeeq Mahdi M; Mahmoud Amin A; Mohammed Ahmed Ali M; Abdelhamid NE; Elmoddather M; Shamselden Yousef H; Hafez EHG; Salem SGT; Soliman AH
    Ocul Immunol Inflamm; 2023 Dec; 31(10):1978-1983. PubMed ID: 36094930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of HLA Profiles in 390 Uveitis Cases: Insights into Clinical Presentations.
    Li S; Yan L; Li M; Fan N
    Altern Ther Health Med; 2023 Nov; 29(8):717-721. PubMed ID: 37708541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Causes of uveitis in a tertiary center in Western Saudi Arabia.
    Nizamuddin SH; Bawazeer AM
    Saudi Med J; 2013 Apr; 34(4):379-87. PubMed ID: 23552591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Patterns and Causes of Intraocular Inflammation in a Uveitis Patient Cohort from Egypt.
    Amin RM; Goweida M; Bedda A; Kamel A; Radwan A
    Ocul Immunol Inflamm; 2019; 27(6):859-867. PubMed ID: 27782772
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical features and long-term treatment outcome of posterior scleritis.
    Lee DH; Cho H; Choi EY; Kim M
    Ann Transl Med; 2022 Nov; 10(21):1162. PubMed ID: 36467362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pattern of uveitis in a referral centre in Tunisia, North Africa.
    Khairallah M; Yahia SB; Ladjimi A; Messaoud R; Zaouali S; Attia S; Jenzeri S; Jelliti B
    Eye (Lond); 2007 Jan; 21(1):33-9. PubMed ID: 16215541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology and characteristics of common forms of anterior uveitis at initial presentation in a tertiary facility in Japan.
    Okazawa R; Iwai S; Nagura K; Sora D; Sato T; Takayama K; Harimoto K; Kanda T; Takeuchi M
    Jpn J Ophthalmol; 2023 Jan; 67(1):22-31. PubMed ID: 36346554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of Uveitis and Scleritis in Nepal: A Tertiary Referral Center Study.
    Manandhar A
    Ocul Immunol Inflamm; 2017; 25(sup1):S54-S62. PubMed ID: 27191731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vogt-Koyanagi-Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report.
    Kikuchi R; Kawagoe T; Hotta K
    BMC Ophthalmol; 2020 Jun; 20(1):252. PubMed ID: 32580711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of Epidemiology of Uveitis in Asia: Pattern of Uveitis in a Tertiary Hospital in the Philippines.
    AbaƱo JM; Galvante PR; Siopongco P; Dans K; Lopez J
    Ocul Immunol Inflamm; 2017; 25(sup1):S75-S80. PubMed ID: 29083984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Characteristics and Treatment of 308 Panuveitis Patients over 10 Years: Results from the KKESH Uveitis Survey Study Group.
    Arevalo JF; Lasave AF; Gupta V; Kozak I; Al Shamsi HN; Al Suliman SM; Al Rushood AA; Al-Zahrani YA; Al-Mahmood AM; Al Dhibi HA;
    Ocul Immunol Inflamm; 2019; 27(8):1296-1304. PubMed ID: 30303435
    [No Abstract]   [Full Text] [Related]  

  • 39. Biological therapy in refractory cases of uveitis and scleritis: An analysis of 18 cases from a tertiary eye care center from South India.
    Sadhu S; Dutta Majumder P; Biswas J
    Indian J Ophthalmol; 2020 Sep; 68(9):1929-1933. PubMed ID: 32823417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular inflammatory disease in patients with polymyalgia rheumatica: A case series and review of the literature.
    Faez S; Lobo AM; Unizony SH; Stone JH; Papaliodis GN; Sobrin L
    Clin Rheumatol; 2016 Jan; 35(1):251-8. PubMed ID: 24696366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.